Biocryst Pharmaceuticals buy JPMorgan Chase & Co.
Start price
06.05.25
/
50%
€9.37
Target price
06.05.26
€11.51
Performance (%)
-20.41%
End price
07.05.26
€7.45
Summary
This prediction ended on 07.05.26 with a price of €7.45. The prediction for Biocryst Pharmaceuticals disappointed with a performance of -20.41%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -8.351% | -8.351% | 3.761% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at JPMorgan Chase & Co. from $10.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.86
20.11.23
20.11.23
€9.15
20.11.24
20.11.24
44.15%
21.11.24
21.11.24
